ArcticZymes AS is pleased to announce the launch of its 1st Ligase in the market. ArcticZymes’ T4 DNA Ligasehas been developed and manufactured under the same strict quality guidelines we apply to all of our enzymes in compliance with ISO 13485. T4 DNA Ligase catalyses the formation of phosphodiester bonds between juxtaposed 5’ phosphate and 3’ hydroxyl termini […]
Bio-Works had 236 active customers at the end of 2018. This means that 131 new customers have been added during the year, which corresponds to an increase of 125 %. Of these customers, six are now working in production scale and another 49 customers are working with scale-up, four of which are working in late […]
– Announces Executive Promotions of Mark Daniels, Patrick Finn, Ph.D., and Patrick Weiss– SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA manufactured on its silicon platform, today announced the appointment of Martin Kunz as senior vice president of operations. His responsibilities will include overseeing global operations together with software development and […]
Gaining insights into inflammatory bowel disease through mass cytometry and Imaging Mass Cytometry analysis of the human mucosal immune system Research aimed at more precise treatments for IMIDs using existing therapies and identification of new targets for drug development SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ: FLDM) today announced it is one of 11 partners in the TIMID Consortium, a […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and simple-to-use tissue image analysis for Imaging Mass Cytometry™ (IMC™). Under the terms of the agreement, Fluidigm and Indica Labs will cooperatively promote the next-generation digital pathology image analysis and image management platforms HALO®, HALO AI™ and HALO Link™ in conjunction with the Fluidigm® Hyperion™ Imaging System, MCD™ Viewer […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of recombinant monoclonal anti-idiotypic antibodies that inhibit the binding of eculizumab (Soliris) to its target, complement C5 protein. These anti-eculizumab antibodies detect free drug and are designed for use in […]
Walkersville, MD (USA) – Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. This partnership expands Lonza’s broad offering of hematopoietic cell lines and enables cell biologists to easily access a wide selection of high-quality cells to boost their scientific research. […]
Adding Decades of Leadership Experience in Personalized Medicine, Digital Health and Life Sciences SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the company’s Board of Directors effective February 5, 2019. Ms. Siegel is Chief Innovation Officer at General Electric (GE) and CEO of GE Ventures. She is responsible for leading the development and acceleration of innovation across GE and built GE […]
New innovations in Invitrogen EVOS M7000 microscope include high-end camera and more powerful computer CARLSBAD, Calif. — For biological researchers requiring high-quality images and data from their cells and samples without over-investing time and resources to get them, the fully automated Invitrogen EVOS M7000 microscope features a high-end camera and more powerful computer to deliver better […]
Israel Parliament Approval is Expected to Catalyze Export of Medical Cannabis; ETCH Biotrace Solution Positioned as Safe and Secure Means to Manage the Legal Supply Chain for Export STONY BROOK, N.Y.–Applied DNA Sciences Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in large-scale PCR-based DNA manufacturing, announced today that two prior announcements by Israel Cannabis […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
